Ruben Mesa, M.D.,Rami S. Komrokji, M.D. Experts Rami Komrokji, MD, and Ruben Mesa, MD, define myeloproliferative neoplasms (MPNs) and explain differences between ...

Key opinion leaders highlight different testing and workup methods involved in making an accurate diagnosis of myeloproliferative neoplasms. Ruben Mesa, M.D.: Rami (Rami Komrokji, M.D.), how would you ...

There can be a delay in diagnosis of myeloproliferative neoplasms as the symptoms of the diseases can be variable and common, such as fatigue, migraines, and difficulty concentrating, explained Ruben ...

Please provide your email address to receive an email when new articles are posted on . John O. Mascarenhas, MD, spoke with Healio about a presentation given during the morning session at 14th ...

This group of cancers remains a challenge to diagnose, can be rapidly progressive, and requires complex treatment and follow-up care, research suggests. Despite recent advancements in treatments for ...

Please provide your email address to receive an email when new articles are posted on . “What I really took away from his presentation was just all of the ways that the inflammatory background of ...

- The Unseen Journey brings to life the often-misunderstood impact of common myeloproliferative neoplasm (MPN) symptoms through AI-generated images developed from the words and experiences of real ...

People who use metformin are less likely to develop a myeloproliferative neoplasm (MPN) over time, indicating that the treatment may help prevent the development of certain types of cancers, according ...

CHICAGO, IL, UNITED STATES, December 14, 2022 /EINPresswire.com/ -- MPN Research Foundation (MPNRF) announces its 2022 Thrive Initiative recipients for projects that ...

—According to a new U.S.-based study, pulmonary hypertension is associated with an increased risk of hematologic progression, adverse cardiovascular events, and all-cause mortality in patients with ...